Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New news soon!!!!

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Mar 04, 2022 10:06pm

257 Views

Post# 34485799

RE:RE:RE:New news soon!!!!

Vikingstock wrote: As discussed below, time to eliminate this notion of a qtr report and release news whenever relevant for public release. The patient study timings and release of data is not in there hands, and would not match a qtr format without delays.

Yep...best to report meaningful data & material info on an "as appropriate" basis in order to avoid potentially empty, less meaningful or delayed quarterly newsletters. Big Pharma/Biotech generally report when appropriate (I.e. larger/statistically significant data sets, Fast Track/BTD status, etc). JMO.

<< Previous

Bullboard Posts

Next >>

Major military / commercial drone supplier has theories over mysterious sightings